Study of Efficacy, Safety and Tolerability of CMK389 in Patients With Chronic Pulmonary Sarcoidosis
Clinical trial NCT04064242 · COMPLETED
Trial details
- NCT number
- NCT04064242
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-23
- Primary completion
- 2023-09-19
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.